Estimate of vertical transmission of Hepatitis C virus in Pakistan in 2007 and 2012 birth cohorts. by Benova, Lenka et al.
Benova, L; Awad, SF; Abu-Raddad, LJ (2017) Estimate of verti-
cal transmission of Hepatitis C virus in Pakistan in 2007 and 2012
birth cohorts. Journal of viral hepatitis. ISSN 1352-0504 DOI:
https://doi.org/10.1111/jvh.12748
Downloaded from: http://researchonline.lshtm.ac.uk/4018305/
DOI: 10.1111/jvh.12748
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
J Viral Hepat. 2017;24:1177–1183.	 	 wileyonlinelibrary.com/journal/jvh	 | 	1177
Received:	4	November	2016  |  Accepted:	6	June	2017
DOI: 10.1111/jvh.12748
O R I G I N A L  A R T I C L E
Estimate of vertical transmission of Hepatitis C virus in 
Pakistan in 2007 and 2012 birth cohorts
Lenka Benova1,2  | Susanne Faissal Awad1 | Laith Jamal Abu-Raddad1,3,4
1Infectious	Disease	Epidemiology	Group,	Weill	
Cornell	Medical	College	-	Qatar,	Cornell	
University,	Qatar	Foundation	-	Education	City,	
Doha,	Qatar
2Faculty	of	Epidemiology	and	Population	
Health,	London	School	of	Hygiene	and	
Tropical	Medicine,	London,	UK
3Department	of	Healthcare	Policy	
and	Research,	Weill	Cornell	Medical	
College,	Cornell	University,	New	York,	NY,	
USA
4College	of	Public	Health,	Hamad	bin	Khalifa	
University,	Doha,	Qatar
Correspondence
Lenka	Benova,	Faculty	of	Epidemiology	and	
Population	Health,	London	School	of	Hygiene	
and	Tropical	Medicine,	London,	UK.
Email:	lenka.benova@lshtm.ac.uk.
Funding information 
This	publication	was	made	possible	by	the	
National	Priorities	Research	Program	(NPRP;	
grant	no.:	NPRP	9-	040-	3-	008)	from	the	
Qatar	National	Research	Fund	(a	member	
of	the	Qatar	Foundation).	The	statements	
made	herein	are	solely	the	responsibility	of	
the	authors.	No	funding	bodies	had	any	role	
in	study	design,	data	collection	and	analysis,	
decision	to	publish	or	preparation	of	the	
manuscript.	The	authors	also	acknowledge	
the	support	provided	by	the	Biostatistics,	
Epidemiology	and	Biomathematics	Research	
Core	at	the	Weill	Cornell	Medical	College	in	
Qatar
Summary
Despite	a	combination	of	high	Hepatitis	C	virus	(HCV)	prevalence,	a	large	adult	popu-
lation	and	high	fertility,	no	published	estimates	of	the	scale	and	contribution	of	vertical	
transmission	to	HCV	incidence	 in	Pakistan	exist.	The	objective	of	this	study	was	to	
estimate	the	number	of	new	HCV	infections	occurring	in	Pakistan	as	a	result	of	vertical	
transmission.	We	adapted	a	published	mathematical	model	based	on	HCV	antibody	
and	viraemia	prevalence,	fertility	rates,	risk	of	HCV	vertical	transmission	and	children	
mortality	rates	to	estimate	the	number	of	infections	in	the	2007	and	2012	birth	co-
horts	nationally	and	in	four	subnational	regions.	We	estimated	that	19	708	(95%	un-
certainty	 interval	 [UI]:	 15	941-	23	819)	 children	were	 vertically	 infected	 by	HCV	 in	
2007	 and	 21	676	 (95%	 UI:	 17	498-	26	126)	 in	 2012.	 The	 majority	 of	 these	 cases	
(72.9%	and	72.5%	in	2007	and	2012,	respectively)	occurred	in	Punjab.	We	estimated	
that	vertical	transmission	as	a	mode	of	exposure	accounted	for	a	quarter	of	HCV	infec-
tions	 among	 children	 under	 5	years	 of	 age	 (25.2%	 in	 2007	 and	 24.0%	 in	 2012).	
Conclusion:	Our	results	showed	that	one	in	260	children	born	in	Pakistan	in	2007	and	
2012	acquired	HCV	vertically.	While	currently	no	interventions	during	pregnancy	and	
childbirth	 are	 recommended	 to	 reduce	 this	 risk,	 prevention,	 testing	 and	 treatment	
strategies	 should	 be	 considered	 to	 reduce	 the	 burden	 of	 vertical	 HCV	 infections	
among	young	children.	Other	routes	of	transmission	appear	to	contribute	the	majority	
of	HCV	infections	among	children	and	must	also	be	clarified	and	urgently	addressed.
K E Y W O R D S
infant,	infectious	disease	transmission,	mother-to-child	transmission,	pregnancy,	transmission	
routes
1  | INTRODUCTION
Pakistan	 is	 a	 country	 with	 one	 of	 the	 highest	 adult	 prevalence	 of	
Hepatitis	C	virus	(HCV)	in	the	world.1	A	recent	systematic	review	es-
timated	a	high	overall	prevalence	of	serological	evidence	of	HCV	in-
fection	(HCV	antibody	[HCV-	Ab]	positivity)	at	>5%	among	the	general	
adult	(15	years	and	older)	population,	but	noted	higher	levels	in	poorer	
rural	and	peri-	urban	areas,	and	among	high-	risk	populations,	such	as	
intravenous	drug	users,	multitransfused	patients,	prisoners	and	dial-
ysis	patients.2	The	most	common	HCV	genotype	in	Pakistan	appears	
to	 be	 3,3	 but	 genotype	 2	 is	 also	widespread	 in	 some	 provinces.2,4,5 
Pakistan	has	the	second	largest	adult	viraemic	population	in	the	world	
at	about	seven	million,1,6	the	vast	majority	of	which	remains	undiag-
nosed.7,8	Its	population	of	189	million	(2015)	is	expected	to	grow	by	
more	than	1.7%	annually	by	2025,9	due	to	a	relatively	high	total	fer-
tility	 rate	 (3.8	per	woman	 in	2012).10	The	combination	of	high	HCV	
prevalence,	a	large	affected	adult	population	and	high	fertility	draws	
Abbreviations:	ASFR,	age-specific	fertility	rates;	CI,	confidence	interval;	DHS,	Demographic	
and	Health	 Surveys;	HCV,	Hepatitis	C	 virus;	HIV,	 human	 immunodeficiency	 virus;	NWFP,	
North-West	Frontier	Province;	UI,	uncertainty	interval.
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focus	 to	 the	potentially	 important	 scale	 and	contribution	of	vertical	
transmission	to	the	HCV	epidemic	in	Pakistan.
Six	 studies	 (none	 nationally	 representative)	 assessed	 HCV-	Ab	
prevalence	 among	 pregnant	women	 and	 found	 that	 it	 ranged	 from	
1.8%	to	8.6%	with	a	mean	of	4.5%,	similar	to	the	level	in	the	general	
population.2	Only	one	of	these	studies,	conducted	in	Karachi,	assessed	
present	HCV	infection	(HCV	RNA	positivity)	among	HCV-	Ab-	positive	
women	(79.7%),11	comparable	to	population-	level	viraemia	prevalence	
among	HCV-	Ab+	cases	globally.1,8,12-14	Nosocomial	transmission	ap-
pears	to	be	the	most	important	contributor	to	the	ongoing	epidemic,	
and	particularly	so	among	women.2,15,16	Factors	 found	to	be	associ-
ated	with	HCV-	Ab	positivity	among	pregnant	women	included	history	
of	 blood	 transfusion,	 therapeutic	 injection	 use,	 surgery	 and	 sharing	
household	 items.17-19	Additionally,	 dental	 procedures	 and	 dilatation	
and	 curettage,	 low	 socio-	economic	 status	 (including	 low	 education	
and	rural	residence)	and	older	age	were	identified	as	associated	with	
HCV-	Ab	positivity	among	females.20-24
The	most	recent	population-	based	nationally	representative	prev-
alence	survey	in	Pakistan	conducted	between	July	2007	and	May	2008	
showed	overall	HCV-	Ab	prevalence	of	4.9%	(95%	CI:	4.7-	5.1),	with	no	
statistically	significant	difference	between	the	sexes.25	Regional	prev-
alence	varied	from	a	high	of	6.7%	(95%	CI:	6.4-	7.0)	in	Punjab	to	1.1%	
in	 (95%	CI:	0.9-	1.3)	 in	 the	North-	West	Frontier	Province	 (NWFP).25 
Prevalence	 among	 children	 under	 5	years	 in	 this	 survey	was	 found	
to	be	1.9%,	meaning	that	based	on	a	population	of	24.7	million	chil-
dren	 in	 this	age	group	 in	2015,9	nearly	half	a	million	children	might	
currently	be	HCV-	Ab+.	A	study	among	1-	to	15-	year-	olds	in	Karachi	
found	 that,	 strikingly,	 none	 of	 the	 assessed	 nosocomial	 exposures	
were	significantly	associated	with	HCV	infection.26	While	there	is	no	
estimate	 of	what	 proportion	 of	 infections	 among	 Pakistani	 children	
might	be	a	result	of	vertical	 transmission,	globally,	vertical	 transmis-
sion	is	thought	to	be	the	most	important	HCV	infection	route	among	
young	children.27-29
The	main	objective	of	this	study	is	to	estimate	the	number	of	an-
nual	HCV	 infections	 resulting	 from	vertical	 transmission	 in	Pakistan.	
The	secondary	objective	is	to	estimate	the	proportion	of	HCV	infec-
tions	among	children	that	arose	as	a	result	of	vertical	transmission.
2  | MATERIALS AND METHODS
2.1 | Model
We	based	our	model	on	a	previously	published	conceptual	framework	
and	modelling	approach,	where	children	born	to	HCV	RNA+	women	
are	exposed	to	the	risk	of	vertical	transmission,30	with	minor	simplifi-
cations	to	reflect	the	nature	of	the	data	available	for	Pakistan.	We	es-
timated	the	number	of	children	infected	vertically	by	HCV	in	Pakistan,	
in	 the	annual	 cohorts	born	 in	2007	and	 in	2012,	nationally	 and	 for	
each	 region.	These	specific	years	were	chosen	based	on	availability	
of	population-	based	nationally	representative	demographic	estimates	
(note	next	subsection	for	further	details)	that	are	temporally	closest	to	
Pakistan’s	national	HCV-	Ab	prevalence	survey	 in	2007-	2008.25 The 
estimated	number	of	vertical	transmissions	was	a	function	of	number	
of	women	in	reproductive	age	(15-	49	years),	their	age-	specific	fertility	
rates	(ASFR,	in	5-	year	age	groups),	HCV-	Ab	prevalence	rates	among	
women	by	age	group,	proportion	of	HCV-	Ab+	women	estimated	to	
be	RNA+,	the	risk	of	HCV	vertical	transmission	and	the	risk	of	dying	
between	birth	and	18	months	of	age	(age	at	which	vertically	acquired	
HCV	can	be	confirmed),	in	2007	and	2012,	as	expressed	in	Equation	1:
In	 this	 equation,	 Ic	 is	 the	 absolute	 number	 of	vertically	 infected	
children	in	a	given	year,	and	ρmHCV+∕RNA+→c	is	the	risk	of	vertical	transmis-
sion	to	children	born	to	HCV-	Ab+/RNA+	women.	The	 index	 i	 labels	
the	 i-	age	group	(5-	year	age	intervals)	in	the	female	population	of	re-
productive	age	(15-	49	years	old)	in	a	given	year.	B(i)	is	the	total	annual	
number	of	births	to	women	in	each	age	group,	based	on	the	number	
of	women	in	each	age	group	and	the	ASFR	in	the	age	group.	ImHCV+ (i)	is	
the	prevalence	of	HCV-	Ab+	among	currently	married	women	in	each	
age	group.	p
m HCV+∕
RNA+ (i)	is	the	proportion	of	HCV-	Ab+	currently	married	
women	in	each	age	group	that	is	RNA+.	XHCV+∕RNA+(i)	is	the	number	of	
children	born	to	HCV-	Ab+/RNA+	mothers	in	a	given	year.	Last,	μ	is	the	
risk	of	dying	between	birth	and	18	months	of	age.
Subnational	 estimates	 were	 calculated	 for	 four	 regions	 (Sindh,	
Punjab,	Balochistan	and	NWFP)	to	assess	the	geographical	distribu-
tion	of	the	burden	of	vertical	transmission	of	HCV	(Equation	2).	In	this	
equation,	Ic
area
	is	the	number	of	children	born	in	a	given	annual	cohort	
who	are	alive	and	vertically	infected	with	HCV	at	age	18	months,	and	
where 
∑4
area=1
Ic
area
= Ic.
The	estimates	for	each	region	were	divided	into	those	occurring	in	
urban	and	rural	areas.
2.2 | Parameters
2.2.1 | Demographic estimates
The	demographic	 estimates	 are	 based	on	 the	 population-	based	 na-
tionally	representative	Demographic	and	Health	Surveys	(DHS),	con-
ducted	 in	 2006-	2007	 and	 2012-	2013.10,31 The number of children 
alive	at	18	months	of	age	from	the	2007	to	2012	birth	cohorts,	 for	
Pakistan	overall	 and	 for	each	of	 the	 four	 regions,	was	estimated.	 It	
was	based	on	 the	number	of	women	 in	 reproductive	age	 (in	5-	year	
age	 groups	 from	15	 to	49	years)	 in	 2007	 and	2012,	 obtained	 from	
the	United	Nations	medium	variant	population	projections,9	and	their	
distribution	in	the	four	regions	and	urban	and	rural	areas	within	each	
region,	based	on	the	most	recent	population	census	from	1998.32 The 
ASFRs	 were	 obtained	 from	 the	 DHS	 reports	 for	 both	 years	 (Table	
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S1).	We	estimated	the	proportion	of	HCV-	infected	infants	from	both	
birth	cohorts	alive	at	18	months	of	age	by	combining	the	infant	mor-
tality	rate	per	1000	live	births	 (0-	11	months)	with	six	months’	 (one-	
eighth)	 equivalent	 of	 the	 child	 mortality	 rate	 per	 1000	 live	 births	
(12-	60	months)	estimated	on	both	DHS	surveys.	The	resulting	mortal-
ity	estimates,	for	Pakistan	as	a	whole,	were	8.03%	(2007)	and	7.61%	
(2012).
2.2.2 | Epidemiological estimates
The	 HCV-	Ab	 prevalence	 as	 measured	 in	 the	 2007-	2008	 national	
survey	was	applied	to	both	birth	cohorts.	The	prevalence	estimates	
were	available	disaggregated	by	age	group	or	by	province	or	by	mari-
tal	 status,	but	not	by	all	 three	population	characteristics.25	HCV-	Ab	
prevalence	among	all	women	was	estimated	for	four	age	groups	(5-	19,	
20-	29,	30-	39	and	40-	49).	We	used	these	estimates	to	model	a	linear	
regression	estimating	prevalence	and	95%	confidence	interval	(CI)	for	
each	one-	year	age	group	and	calculating	an	average	for	each	5-	year	
age	 group	between	 ages	15	 and	49.	We	 then	 scaled	 the	 estimates	
for	 each	of	 the	 seven	5-	year	 age	 groups	 to	 reflect	 the	60%	higher	
prevalence	found	on	the	survey	among	women	who	are	at	risk	of	con-
ception	and	birth	(currently	married	women	aged	20-	49),	and	to	esti-
mate	the	HCV-	Ab	prevalence	for	each	age	group	by	region	(Figure	1,	
Table	1).
As	HCV	RNA	positivity	was	not	measured	in	the	national	survey,	
we	used	estimates	of	the	percentage	of	HCV-	Ab+	women	with	RNA+	
estimated	 from	a	 survey	of	pregnant	women	 in	Karachi.11	This	per-
centage	was	not	available	by	women’s	age	group,	and	one	estimate	
(79.7%)	was	thus	applied	to	all	age	groups.	The	risk	of	vertical	trans-
mission,	 diagnosed	 at	 18	months	 of	 age,	was	 estimated	 based	on	 a	
recent	meta-	analysis	 at	 5.8%	 (95%	CI:	 4.2-	7.8).33	The	 one	 study	 of	
risk	of	vertical	transmission	conducted	in	Pakistan	did	not	significantly	
differ	from	this	estimate	of	risk	(3.9%	[95%	CI:	0.6-	7.2],	according	to	
the	 above	 definition).34	The	 risk	 of	vertical	 transmission	 used	 is	 for	
children	of	human	immunodeficiency	virus	(HIV)	negative	women,	as	
HIV	prevalence	in	Pakistan	was	very	low	at	<0.1%	according	to	2013	
estimates	for	adults	aged	15-	49.35
2.2.3 | Uncertainty analyses
Uncertainty	analyses	were	performed	to	specify	the	ranges	of	uncer-
tainty	in	the	national	and	regional	estimates	for	the	number	of	children	
vertically	infected	by	HCV	with	respect	to	variations	in	the	structural	
parameters	of	the	model.	The	parameters	that	were	varied	included	
the	following:	prevalence	of	HCV-	Ab	among	currently	married	women	
by	age	group	(ImHCV+ (i)),	the	proportion	of	HCV-	Ab+	currently	married	
women	 that	 are	 RNA+	 (p
m HCV+∕
RNA+ (i))	 and	 the	 risk	 of	 vertical	 transmis-
sion	 to	 children	born	 to	HCV-	Ab+/RNA+	women	 (ρmHCV+∕RNA+→c).	We	
implemented	20	000	runs	of	the	model	using	Monte	Carlo	sampling	
from	binomial	probability	distributions	incorporating	the	sample	sizes	
of	the	source	studies	for	the	parameters	of	the	model.	Distributions	
for	 the	estimated	number	of	children	 infected	were	then	generated	
and	used	to	determine	the	mean	values	and	associated	95%	uncer-
tainty	intervals	(UIs).
2.3 | Contribution of vertical transmission to 
incidence among children
We	were	unable	to	identify	any	study	estimating	incidence	of	HCV	or	
risk	factors	for	HCV	infection	among	children	in	Pakistan.	In	order	to	
assess	the	contribution	of	vertical	transmission	to	the	burden	of	HCV	
infection	among	children,	we	used	our	estimate	of	the	number	of	an-
nual	HCV	cases	resulting	from	vertical	transmission,	multiplied	by	five	
and	 expressed	 these	 as	 a	 percentage	 of	 all	HCV-	Ab+	 cases	 among	
children	under	5	years.	We	calculated	the	expected	total	number	of	
HCV-	Ab+	cases	among	children	under	5	years	 in	Pakistan	using	the	
F IGURE  1 Estimates	of	HCV-	Ab	
prevalence	among	currently	married	
women	15-	49	yr	of	age	in	Pakistan,	
nationally	and	by	region,	by	age	group	
NWFP,	North-	West	Frontier	Province.	
Source:	Pakistan	Medical	Research	Council,	
Prevalence of Hepatitis B&C in Pakistan. 
Pakistan	Medical	Research	Council:	
Islamabad,	Pakistan
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United	Nations	population	projections	for	the	years	2007	and	2012,9 
and	HCV-	Ab	prevalence	and	95%	CI	in	this	age	group	from	the	HCV	
2007-	2008	national	survey.25	The	uncertainty	 intervals	for	the	esti-
mated	proportions	of	HCV-	Ab+	cases	among	children	under	5	years	
of	age	due	to	vertical	transmission	in	2007	and	2012	were	calculated	
using	the	95%	CI	of	HCV-	Ab	prevalence	and	95%	UIs	of	the	estimated	
numbers	of	vertical	transmissions.
3  | RESULTS
We	estimated	that	in	2007,	a	total	of	5.1	million	live	births	occurred	to	
women	aged	15-	49.	By	the	time,	this	annual	birth	cohort	reached	the	
age	of	18	months,	the	number	of	children	alive	with	vertically	trans-
mitted	HCV	was	estimated	at	19	708	(95%	UI:	15	941-	23	819).	The	
number	of	births	in	2012	was	estimated	at	5.6	million,	and	the	result-
ing	number	of	vertically	transmitted	HCV	cases	was	21	676	(95%	UI:	
17	498-	26	126).
The	 majority	 of	 these	 vertically	 transmitted	 cases	 (65.1%	 and	
65.0%	in	2007	and	2012,	respectively)	occurred	in	rural	areas,	reflect-
ing	the	population	distribution	(Figure	2).	Nearly	three-	quarters	of	all	
cases	(72.9%	and	72.5%	in	2007	and	2012,	respectively)	occurred	in	
Punjab,	which	was	also	the	only	region	where	the	proportion	of	over-
all	vertical	 infections	was	greater	 than	the	proportion	of	 total	births	
(Figure	3).	The	lowest	proportion	of	all	vertical	infections	in	Pakistan	
was	estimated	 to	occur	 in	Balochistan	 (<2%	of	vertical	 infections	 in	
both	annual	cohorts).
Based	on	 the	population	of	 children	under	5	years	and	HCV-	Ab	
prevalence	in	this	age	group	from	the	2007	to	2008	national	survey,	
we	estimated	that	a	total	of	391	084	(95%	CI:	308	751-	473	418)	chil-
dren	were	HCV-	Ab+	in	2007	and	451	074	(95%	CI:	356	111-	546	036)	
in	 2012.	Vertical	 transmission	 as	 a	mode	 of	 exposure	 therefore	 ac-
counted	 for	 approximately	 a	 quarter	 of	 HCV	 infections	 in	 this	 age	
group	in	both	years	(25.2%	[UI	16.8%-	38.6%]	in	2007	and	24.0%	[UI	
16.0%-	36.7%]	in	2012).
4  | DISCUSSION
This	is	the	first	study	to	estimate	the	absolute	number	and	the	con-
tribution	of	vertical	transmission	to	HCV	prevalence	among	children	
in	Pakistan,	one	of	the	countries	most	affected	by	HCV.	To	produce	
our	estimates,	we	adapted	a	published	methodology	and	used	quality	
epidemiological	and	demographic	input	data.	We	found	that	~20	000	
children	 acquire	 HCV	 annually	 as	 a	 result	 of	 vertical	 transmission.	
While	 fewer	 than	60%	of	Pakistan’s	population	 lives	 in	Punjab,	 this	
region	 accounted	 for	 three-	quarters	 of	 HCV	 vertical	 transmissions	
due	to	the	highest	HCV	prevalence	among	the	four	regions	examined.	
Under	 the	 assumption	 that	 the	 prevalence	 of	 HCV	 among	women	
of	 reproductive	age	remained	similar	 to	 the	 levels	measured	on	the	
2007-	2008	 national	 survey,	 vertical	 transmission	 would	 have	 pro-
duced	nearly	150	thousand	new	HCV	cases	in	Pakistan	in	the	9	years	
between	2007	and	2015.T
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Vertical	transmission	of	HCV	infection	was	estimated	recently	for	
Egypt.30	While	 Egypt	 appears	 to	 have	 the	 highest	 HCV	 prevalence	
worldwide,12,13,36	our	estimate	of	the	number	of	HCV	vertical	trans-
mission	 cases	 in	 Pakistan	 is	 fourfold	 higher	 than	 that	 in	 Egypt.	The	
larger	population	size	in	Pakistan	(189	million	vs	92	million	in	Egypt	in	
20159)	explains	a	large	part	of	this	difference.	Unlike	in	Egypt,	where	
men	have	a	higher	HCV	prevalence,	difference	between	the	sexes	is	
not	significant	in	Pakistan.25	The	fact	that	two	regions	with	the	largest	
populations	 (Punjab	and	Sindh)	also	have	the	highest	HCV-	Ab	prev-
alence	 creates	 a	 combination	 of	 demographic	 and	 epidemiological	
factors	 resulting	 in	a	 large	burden	of	vertical	HCV	 infections.	Lastly,	
women	of	reproductive	age	who	are	30	years	old	and	above,	who	have	
the	highest	prevalence	of	HCV-	Ab	(particularly	in	the	two	most	popu-
lous	regions),	also	have	unusually	high	fertility	levels	(ASFRs	32%-	75%	
higher	than	in	Egypt,	depending	on	age	group).
Our	study	has	several	 limitations,	pertaining	primarily	to	the	un-
availability	 of	 raw	 data	 on	 HCV-	Ab	 prevalence,	 which	 would	 have	
enabled	us	 to	calculate	prevalence	disaggregated	by	sex,	age	group,	
marital	 status,	 region	 and	 urban/rural	 residence.	 To	 deal	 with	 this	
issue,	we	scaled	the	prevalence	for	currently	married	women	and	by	
region	and	interpolated	prevalence	for	the	5-	year	age	groups	in	order	
to	 correspond	with	 demographic	 estimates	 of	 fertility.	As	 disaggre-
gated	data	were	not	available,	we	used	HCV	prevalence	 in	each	 re-
gion	for	both	urban	and	rural	areas	within	regions.	The	risk	of	vertical	
transmission	might	also	differ	in	urban	and	rural	areas;	some	of	these	
differentials	might	be	due	to	variable	proportions	of	births	occurring	in	
healthcare	versus	home	setting	and	related	infection	control	practices.	
We	applied	the	same	risk	of	vertical	transmission	for	both	area	types	
as	we	were	unable	to	find	rigorous	studies	assessing	the	extent	and	
mechanisms	of	this	differential	in	low-	and	middle-	income	countries.	
F IGURE  2 Estimated	number	of	vertical	
HCV	infections	by	annual	birth	cohort	and	
region	(urban	and	rural),	2007	and	2012.	
NWFP,	North-	West	Frontier	Province
F IGURE  3 Estimated	percentages	
of	all	births	in	Pakistan	(outer	circle)	and	
percentages	of	vertical	HCV	infections	
in	Pakistan	(inner	circle)	by	region,	2007	
and	2012.	Outer	circles	represent	the	
distribution	of	all	births	in	Pakistan	and	
the	inner	circles	the	distribution	of	vertical	
HCV	infection	in	Pakistan	by	region.	NWFP,	
North-	West	Frontier	Province
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Similarly,	we	were	unable	 to	 identify	 studies	estimating	 the	 specific	
effect	of	HCV	infection	on	women’s	fertility	or	the	risk	of	mortality	for	
infants	between	12	and	18	months	of	age;	we	applied	nondifferential	
population-	representative	estimates	in	our	model.
Second,	 some	women	with	 recent	 infection	might	 be	 at	 risk	 of	
transmitting	 the	 virus	 (HCV	 RNA	 positive)	 but	 not	 yet	 have	 devel-
oped	HCV	antibodies,	and	thus	would	not	be	reflected	in	the	HCV-	Ab	
prevalence	estimates.	However,	this	number	is	likely	to	be	negligible	
and	was	excluded	from	the	model	as	we	had	not	identified	any	study	
measuring	 HCV-	Ab-	/RNA+	 prevalence	 among	 women	 in	 Pakistan.	
Third,	 nationally	 representative	 estimate	 for	 HCV-	Ab	 prevalence	
was	available	only	for	1	year,	2007-	2008,	and	prevalence	could	have	
changed	since	then.	We	assumed	stable	prevalence	since	2007-	2008.	
The	increase	in	the	estimated	number	of	vertical	infections	and	slight	
changes	in	the	regional	distribution	of	vertical	infections	are	therefore	
solely	due	to	population	dynamics	 (population	numbers,	distribution	
and	fertility	rates)	rather	than	due	to	a	combination	of	population	dy-
namics	and	infection	dynamics.	Fourth,	neither	the	2007-	2008	HCV	
national	 survey	 nor	 the	 2006-	2007	 and	 2012-	2013	 DHS	 covered	
some	remote	or	disputed	regions	of	Pakistan	(Federally	Administered	
Tribal	Area	 and	Jammu/Kashmir).	However,	 these	 areas	 account	 for	
<3%	of	Pakistan’s	population,	31,32	and	it	is	therefore	unlikely	that	our	
estimates’	 accuracy	was	 significantly	compromised	by	 this	omission.	
Last,	further	clearance	of	HCV	viraemia	might	occur	among	vertically	
infected	 children	 beyond	 the	 age	 of	 18	months,	 and	 studies	 have	
noted	 higher	 clearance	 for	HCV	 transmitted	 vertically	 compared	 to	
other	 routes.37,38	Our	 results	might	 therefore	have	 slightly	overesti-
mated	the	true	burden	of	vertically	transmitted	HCV	in	Pakistan.
While	children	with	vertically	acquired	HCV	appear	to	have	mild	
disease	progression,39	no	interventions	during	pregnancy	or	childbirth	
are	currently	recommended	for	the	prevention	of	HCV	vertical	trans-
mission.37	Population-	level	strategies	to	prevent	vertical	infections	in	
Pakistan	might	include	addressing	HCV	transmission	routes	affecting	
girls	and	women	in	reproductive	age,	HCV	testing	and	linkage	to	post-
pregnancy	 treatment,	 and	 reducing	 unmet	 need	 for	 modern	 family	
planning	 methods	 which	 could	 help	 reduce	 unwanted	 pregnancies	
among	HCV-	Ab+	women.10	While	the	safety	of	direct-	acting	antivirals	
(DAAs)	administration	during	pregnancy	has	not	yet	been	established,	
there	 is	 optimism	 about	 this	 possibility,	 unlike	 the	 older	 ribavirin-	
containing	 therapies.	 Encouragingly,	 generic	 DAA	 production	 has	
already	started	in	Pakistan	with	prospects	for	reducing	the	cost	of	a	
treatment	regimen	to	as	little	as	$100.	With	such	vastly	reduced	treat-
ment	costs,	an	important	consideration	in	cost-	effectiveness	analyses	
is	that	undiagnosed	and	untreated	HCV	infection	expose	chronically	
vertically	 infected	children	to	 long	periods	of	chronic	 illness	and	se-
quelae	that	can	be	a	far	more	financially	and	socially	expensive	burden	
than	the	cost	of	treatment.
In	conclusion,	our	 results	 showed	 that	one	 in	260	children	born	
in	Pakistan	in	the	two	annual	birth	cohorts	assessed	in	this	study	ac-
quired	HCV	vertically.	This	 ratio	 reached	 one	 in	 205	 in	 Punjab,	 the	
worst	affected	region.	While	we	showed	that	vertical	transmission	in	
the	high	HCV	prevalence	and	high	fertility	context	of	Pakistan	 is	an	
issue	of	public	health	importance,	this	should	not	detract	from	other	
efforts	to	identify	and	reduce	other	HCV	transmission	routes	which,	
according	to	our	estimates,	appear	to	constitute	the	majority	of	HCV	
infections	among	children	under	5	years	of	age.
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